Peptide Encyclopaedia
Glutathione
Also known as GSH, γ-glutamyl-cysteinyl-glycine.
Approved-medicine listing only. This is not available from the Cellular Sequence shop. Licensed products require a prescriber and an ARTG-registered presentation.
At-a-glance profile
- Classification
- Endogenous tripeptide antioxidant
- Approval status
- Approved medicine
- Research status
- Labelled indications are defined in product information.
- Molecular formula
- Insufficient reliable evidence identified.
- Molecular weight
- Insufficient reliable evidence identified.
- Sequence
- Glu-Cys-Gly. Licensed uses exist in specific presentations; high-dose IV ‘whitening’ vials are another matter.
- Primary biological target
- Insufficient reliable evidence identified.
- Half-life
- Insufficient reliable evidence identified.
- Routes investigated
- Insufficient reliable evidence identified.
- Human evidence level
- A — Approved clinical use / strong human evidence
What is it?
The body’s main thiol antioxidant. High-dose injectable glutathione sold for skin lightening is not an approved cosmetic here and is not sold.
Mechanism of action
Redox buffering and conjugation reactions.
Systemic redox change; IV use has been associated with serious adverse events when unregulated.
What is it being studied for?
- Selected licensed supportive uses
- Unapproved cosmetic IV markets
Investigational findings are not proven clinical benefits unless an authority has labelled that indication.
Evidence level
Overall human evidence grade: A · Approved clinical use / strong human evidence
Human research
Endogenous biochemistry is known; cosmetic IV evidence is poor and safety is not benign.
Preclinical research
Animal, cell and in-vitro findings are listed separately from human effects.
Textbook redox biology.
Doses reported in published research
This section does not provide personalised medical dosing. Values are those reported in papers or protocols. Animal mg/kg doses are not converted to human doses.
Doses reported in human studies
Insufficient reliable evidence identified.
Preclinical / animal study dosing
Insufficient reliable evidence identified.
Pharmacokinetics
Reliable human pharmacokinetic data were not identified for this encyclopaedia entry, or are limited to product information for approved presentations.
Safety
Anaphylactoid reactions and liver injury reports with unregulated IV use.
Unknowns. Absence of a published harm signal is not evidence of safety.
Contraindications. Do not use unlicensed IV glutathione.
Regulatory status
Ingredient/medicine status depends on presentation; research ‘GTT’ vials are not licensed IV therapy.
Cellular Sequence does not sell this as a vial, tablet, oil, or injectable. Educational encyclopaedia listing only.
Citations
[1] Encyclopaedia note
Encyclopaedia note
For educational and research reference only. This page summarises published scientific literature and does not constitute medical advice, prescribing information or a recommendation to use an investigational compound. Research doses shown describe doses reported in published studies and are not personalised dosing instructions.
Last reviewed 2026-09-13. Research areas: Skin & Hair, Healthy Ageing · Compare peptides